Baber R J, Studd J W
Dulwich Hospital, London.
Br J Hosp Med. 1989 Feb;41(2):142, 144-6, 148-9.
The benefits of hormone replacement therapy in alleviating climacteric symptoms, preventing osteoporosis and reducing the incidence of cardiovascular disease and stroke are now generally agreed. Nonetheless, perhaps only 5% of postmenopausal women currently receive adequate treatment often because of patient or clinician fears that such treatment may be associated with harmful side effects.
